Statistics

	Views
Early efficacy results in the Alumites study: A randomized, controlled, multicenter, phase IV study with house dust mites subcutaneous immunotherapy. Two months symptoms and medication scores	43

Select a period of time:

	Views
Early efficacy results in the Alumites study: A randomized, controlled, multicenter, phase IV study with house dust mites subcutaneous immunotherapy. Two months symptoms and medication scores	25

RUNA digital repository